홈 › 만성 림프구성 백혈병 › 미네소타 › Rochester
MN Rochester의 만성 림프구성 백혈병 임상 시험
만성 림프구성 백혈병 관련 연구 19개가 Rochester 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
피험자 모집 중1/2상
- Research Site, Rochester
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
피험자 모집 중3상
- Mayo Clinic Rochester, Rochester
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
피험자 모집 중3상
- Mayo Clinic Rochester, Rochester
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
피험자 모집 중1/2상
- Mayo Clinic Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
피험자 모집 중3상
- Mayo Clinic Rochester, Rochester
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
피험자 모집 중1상
- Mayo Clinic Rochester, Rochester
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
피험자 모집 중1/2상
- Mayo Clinic, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
피험자 모집 중1/2상
- Mayo Clinic, Clinical Trials Referral Office, Rochester
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
피험자 모집 중2상
- Mayo Clinic in Rochester, Rochester
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
피험자 모집 중2상
- Mayo Clinic, Rochester
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
피험자 모집 중1상
- Mayo Clinic in Rochester, Rochester
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
피험자 모집 중건강한 지원자 환영
- Mayo Clinic in Rochester, Rochester
Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
피험자 모집 중관찰 연구건강한 지원자 환영
- Mayo Clinic in Rochester, Rochester
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
피험자 모집 중2상
- Mayo Clinic in Rochester, Rochester
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
피험자 모집 중4상
- Mayo Clinic- Minnesota, Rochester
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
피험자 모집 중4상
- Mayo Clinic- Minnesota, Rochester
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
피험자 모집 중관찰 연구
- Mayo Clinic in Rochester, Rochester
Family Study of Lymphoproliferative Disorders
피험자 모집 중관찰 연구건강한 지원자 환영
- Mayo Clinic, Rochester
Q702 for the Treatment of Patients With Hematologic Malignancies
피험자 모집 중1상
- Mayo Clinic in Rochester, Rochester
다른 도시의 만성 림프구성 백혈병 시험
- Boston, MA연구 31개
- Columbus, OH연구 29개
- Durham, NC연구 27개
- Washington, DC연구 22개
- Seattle, WA연구 21개
- New York City, NY연구 18개
- Houston, TX연구 17개
- Baldwin Park, CA연구 16개
- Milwaukee, WI연구 14개
- Chicago, IL연구 14개
- Cincinnati, OH연구 14개
- Nashville, TN연구 13개
Rochester의 다른 연구
- 유방암연구 42개
- 비소세포폐암연구 37개
- 암 (전체)연구 30개
- 전이성 암연구 30개
- 난소암연구 29개
- 대장직장암연구 29개
- 다발성 골수종연구 24개
- 췌장암연구 23개
- 심부전연구 22개
- 전립선암연구 22개
- 폐암연구 20개
- 자궁내막암연구 19개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.